In Silico Trials, Real Impacts!

UK CEiRSI | InSilicoUK
  • 5.0 (1)
  • CIENCIAS DE LA VIDA

๐—œ๐—ป ๐—ฆ๐—ถ๐—น๐—ถ๐—ฐ๐—ผ ๐— ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ถ๐—ป๐—ฒ ๐—ฅ๐—ฒ๐˜ƒ๐—ผ๐—น๐˜‚๐˜๐—ถ๐—ผ๐—ป: ๐—จ๐—ž ๐—–๐—˜๐—ถ๐—ฅ๐—ฆ๐—œโ€™๐˜€ ๐—ข๐—ณ๐—ณ๐—ถ๐—ฐ๐—ถ๐—ฎ๐—น ๐—ฃ๐—ผ๐—ฑ๐—ฐ๐—ฎ๐˜€๐˜ on ๐—ฉ๐—ถ๐—ฟ๐˜๐˜‚๐—ฎ๐—น ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ง๐—ฟ๐—ถ๐—ฎ๐—น๐˜€ & ๐—›๐—ฒ๐—ฎ๐—น๐˜๐—ต๐—ฐ๐—ฎ๐—ฟ๐—ฒ ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป Welcome to the official podcast of the ๐—จ๐—ž ๐—–๐—ฒ๐—ป๐˜๐—ฟ๐—ฒ ๐—ผ๐—ณ ๐—˜๐˜…๐—ฐ๐—ฒ๐—น๐—น๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ผ๐—ป ๐—œ๐—ป ๐—ฆ๐—ถ๐—น๐—ถ๐—ฐ๐—ผ ๐—ฅ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐˜๐—ผ๐—ฟ๐˜† ๐—ฆ๐—ฐ๐—ถ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ฎ๐—ป๐—ฑ ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป (๐—จ๐—ž ๐—–๐—˜๐—ถ๐—ฅ๐—ฆ๐—œ) and the ๐—œ๐—ป๐—ฆ๐—ถ๐—น๐—ถ๐—ฐ๐—ผ๐—จ๐—ž ๐—ฃ๐—ฟ๐—ผ ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ฅ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€ ๐—ก๐—ฒ๐˜๐˜„๐—ผ๐—ฟ๐—ธ. Discover how ๐—ฐ๐—ผ๐—บ๐—ฝ๐˜‚๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—บ๐—ผ๐—ฑ๐—ฒ๐—น๐—น๐—ถ๐—ป๐—ด and ๐˜ƒ๐—ถ๐—ฟ๐˜๐˜‚๐—ฎ๐—น ๐—ฐ๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐˜๐—ฟ๐—ถ๐—ฎ๐—น๐˜€ are transforming healthcare: ๐Ÿ”ฌ ๐——๐—ถ๐—ด๐—ถ๐˜๐—ฎ๐—น ๐—›๐—ฒ๐—ฎ๐—น๐˜๐—ต ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป: Explore breakthrough virtual testing methods for medical devices and pharmaceuticals ๐Ÿฅ ๐—›๐—ฒ๐—ฎ๐—น๐˜๐—ต๐—ฐ๐—ฎ๐—ฟ๐—ฒ ๐—ง๐—ฒ๐—ฐ๐—ต๐—ป๐—ผ๐—น๐—ผ๐—ด๐˜†: Learn about ๐—ถ๐—ป ๐˜€๐—ถ๐—น๐—ถ๐—ฐ๐—ผ evidence revolutionising patient care ๐Ÿ’ป ๐—–๐—ผ๐—บ๐—ฝ๐˜‚๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐— ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ถ๐—ป๐—ฒ: Understand how ๐—ฑ๐—ถ๐—ด๐—ถ๐˜๐—ฎ๐—น ๐˜๐˜„๐—ถ๐—ป๐˜€ and computer simulations accelerate drug development ๐Ÿค ๐—ฅ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐˜๐—ผ๐—ฟ๐˜† ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป: Join experts discussing streamlined approval processes for medical innovations ๐Ÿ“ˆ ๐—›๐—ฒ๐—ฎ๐—น๐˜๐—ต๐—ฐ๐—ฎ๐—ฟ๐—ฒ ๐—˜๐—ฐ๐—ผ๐—ป๐—ผ๐—บ๐—ถ๐—ฐ๐˜€: Explore cost-effective solutions driving medical advancement ๐Ÿ”” ๐——๐—ผ๐—ปโ€™๐˜ ๐—บ๐—ถ๐˜€๐˜€ ๐—ผ๐˜‚๐˜! Follow us across platforms to stay updated with the latest in ๐—ถ๐—ป ๐˜€๐—ถ๐—น๐—ถ๐—ฐ๐—ผ innovations, regulatory developments, and groundbreaking research. Join the conversation and become part of the ๐—จ๐—ž ๐—–๐—˜๐—ถ๐—ฅ๐—ฆ๐—œ community shaping the future of healthcare! ๐Ÿš€

  1. 30 JUN

    Digital Twins & Virtual Patients: Revolutionising Paediatric Clinical Trials

    Join us for an eye-opening exploration of how virtual patient data is revolutionising paediatric clinical trials. In our upcoming episode, we delve into groundbreaking research that addresses one of healthcare's most pressing challenges: the power crisis plaguing paediatric randomised controlled trials. Discover how digital twins, synthetic patient data, and in silico trials are offering unprecedented solutions to reduce children's exposure to unproven therapies whilst accelerating drug approvals. We'll examine the transformative potential of these technologies in creating personalised treatment options at significantly lower costs, ultimately leading to faster clinical implementation of life-saving interventions. However, innovation comes with responsibility. Our discussion critically evaluates the ethical and regulatory frameworks necessary to ensure safe, sustainable adoption of virtual patient data in paediatric medicine. Join our interactive webinar to engage directly with experts and explore how these digital innovations are shaping the future of children's healthcare. Source: Pammi M, Shah PS, Yang LK, Hagan J, Aghaeepour N, Neu J. Digital twins, synthetic patient data, and in-silico trials: can they empower paediatric clinical trials? Lancet Digit Health. 2025

    28 min

  2. 23 JUN

    Beyond the Scalpel: How Computer Models Are Rewriting Paediatric Heart Surgery

    This episode explores groundbreaking research from Boston Children's Hospital and Harvard Medical School that demonstrates how multiphysiologic state computational fluid dynamics (CFD) modelling is transforming surgical planning for children with complex congenital heart conditions. We delve into the innovative 3D virtual surgery workflow developed for patients with single ventricle physiology and interrupted inferior vena cava - a particularly challenging combination that historically carries high risks of life-threatening complications. The research team's approach utilises advanced CFD analysis across multiple physiological states to predict and optimise hepatic venous flow distribution, preventing the formation of pulmonary arteriovenous malformations that can prove fatal in these vulnerable young patients. The episode examines how this in silico methodology successfully translates virtual surgical planning into real-world clinical outcomes, validated through post-operative MRI imaging. We discuss the broader implications for personalised paediatric medicine, the potential for reducing surgical revisions, and how computational modelling is enabling surgeons to achieve balanced blood flow patterns that were previously difficult to predict using traditional planning methods. This case study exemplifies the transformative potential of digital health technologies in paediatric care, showcasing how sophisticated computational tools can directly improve surgical outcomes and quality of life for children with complex cardiac conditions. Source: Hoganson DM, Govindarajan V, Schulz NE, Eickhoff ER, Breitbart RE, Marx GR, Del Nido PJ, Hammer PE. Multiphysiologic State Computational Fluid Dynamics Modeling for Planning Fontan With Interrupted Inferior Vena Cava. JACC Adv. 2024 Jun 13;3(7):101057.

    22 min

  3. 16 JUN

    Future-Proofing the UK Life Sciences Sector

    Are you prepared for the seismic shift transforming UK life sciences careers? This latest "In Silico Trials, Real Impacts!" episode reveals how AI and in silico technologies are creating unprecedented employment opportunities across health tech sectors.  Discover the essential skills driving this revolution, from computational biology to digital therapeutics, and why lifelong learning has become non-negotiable. We examine the geographical spread of emerging roles and explore how international talent maintains Britain's competitive advantage in global markets. What does this transformation mean for traditional biologists, chemists, and clinicians as digital tools reshape their practice? How are government initiatives preparing the next generation for these evolving demands?  Uncover the real-world implications for patient care and economic growth in this data-driven analysis of our industry's future. Sources: Lightcast (2024), The UK Skills Revolution: Building a Data-Driven Skills System in an Era of Disruption https://lightcast.io/resources/research/uk-skills-revolution-25 Lightcast, ABHI, ABPI, and BIA (2025) Life Sciences 2035: Developing the Skills for Future Growth https://www.abpi.org.uk/publications/life-sciences-2035-developing-the-skills-for-future-growth-main-report/

    17 min

  4. 9 JUN

    Exploring the Limitations and Potentials of RCTs: Beyond the Gold Standard

    Are Randomised Controlled Trials (RCTs) always the definitive 'gold standard' in research? In the latest episode of In Silico Trials, Real Impacts!, we explore the nuanced landscape of RCTs, questioning their universal applicability and examining the complexities they often obscure. While RCTs are celebrated for their rigour, this discussion delves into their limitations, particularly when findings are applied across diverse contexts. Drawing on seminal work by Deaton and Cartwright (2018), this episode highlights the critical role that RCTs play in the medical and social sciences, while underscoring the importance of complementing them with observational studies and theoretical frameworks. Ethical considerations and the need for a more integrated approach to research take centre stage, offering a fresh perspective on evidence generation. Whether you're a researcher, healthcare professional, or simply curious about scientific methodologies, this episode provides thought-provoking insights into the evolving landscape of research. Source: Deaton A, Cartwright N. Understanding and misunderstanding randomized controlled trials. Soc Sci Med. 2018 Aug;210:2-21.

    33 min

  5. 2 JUN

    Simpler or Complex: Rethinking Occam's Razor in Modelling Science

    Is simplicity always the smartest choice in science? Or could complexity be the key to groundbreaking discoveries? This episode explores the evolving role of simplicity and complexity in scientific modelling, questioning the age-old principle of Occam's razor in light of modern advancements: Plurality should not be posited without necessity.  Discover how digital approaches, from computational modelling to simulated clinical trials, are reshaping medical product development, making healthcare safer, more efficient, and unexpectedly precise. As we journey through recent research and breakthroughs, you'll gain insights into the tension between simple and complex scientific models, and how they impact the healthcare landscape. Whether you're a researcher, regulator, patient representative, or just curious about the future of medicine, this episode unpacks the concept of parsimony and its implications, especially as technology progresses. Learn about the balance between simplicity and complexity and how they complement each other as tools in science.   Source: Dubova M, Chandramouli S, Gigerenzer G, Grรผnwald P, Holmes W, Lombrozo T, Marelli M, Musslick S, Nicenboim B, Ross LN, Shiffrin R, White M, Wagenmakers EJ, Bรผrkner PC, Sloman SJ. Is Ockham's razor losing its edge? New perspectives on the principle of model parsimony. Proc Natl Acad Sci U S A. 2025 Feb 4;122(5):e2401230121.

    28 min

  6. 25 MAY

    Evaluating Continuous Glucose Monitoring Sensors with in Silico Trials: A Real-World Exemplar

    Could computer simulations redefine diabetes care? In this episode, we focus on a real medical product and the role of in silico trials in the transition from the Medtronic Guardian Sensor 3 to the Guardian 4 sensor, central to the Medtronic 780G pump system, which aims to simplify diabetes management by eliminating the need for fingerstick calibrations. Discover how computer simulations, clinical studies, and real-world data converge to evaluate this significant shift, revealing slight shifts in glucose metrics but proving the reliability of in silico methods in predicting real outcomes. Join us to uncover the potential of digital modeling to transform healthcare, making it more precise while retaining safety, and contemplate how these advances might accelerate personalized medicine delivery, bypassing some traditional trial limitations. Source: Grosman B, Parikh N, Roy A, Lintereur L, Vigersky R, Cohen O, Rhinehart A. In Silico Evaluation of the Medtronic 780G System While Using the GS3 and Its Calibration-Free Successor, the G4S Sensor. Ann Biomed Eng. 2023 Jan;51(1):211-224.

    16 min

  7. 19 MAY

    Unveiling Evidence-Based Medicine Plus and Mechanistic Reasoning

    What is Evidence-Based Medicine Plus? This podcast episode explores the transformative power of computational modelling and simulated clinical trials in medical innovation. Discover the significance of evidence-based medicine (EBM) and evidential pluralism, emphasising the role of mechanistic evidence alongside traditional studies. Join us as we delve into compelling examples like mobile phone radiation and ACE inhibitors, highlighting how these insights enhance the external validity of treatments. Perfect for researchers and regulators alike, or anyone interested in the evolving landscape of medicine. Sources: Russo F, Williamson J. Epistemic causality and evidence-based medicine. Hist Philos Life Sci. 2011;33(4):563-81. Parkkinen, V.-P., Wallmann, C., Wilde, M., Clarke, B., Illari, P., Kelly, M. P., Norell, C., Russo, F., Shaw, B., & Williamson, J. (Eds.). (2023). Evaluating Evidence of Mechanisms in Medicine: Principles and Procedures. Oxford University Press.

    17 min

  8. 12 MAY

    What Underpins Model Credibility? Three Philosophical Perspectives

    How do philosophers of science think about model evaluation? Dive deep into the crucial process of model evaluation, a fundamental step in digital science that determines the effectiveness and precision of computational models. This episode explores three primary perspectives on model quality: the mirror view, relevant similarity, and fitness for purpose. Learn about the complexities and challenges involved in evaluating models, from data limitations to the intricate balance between accuracy and usability. Whether you're a researcher, regulator, or a curious listener, discover how these cutting-edge methodologies are reshaping healthcare, improving safety, efficiency, and equitability, one simulated trial at a time. Join us as we delve into the philosophy behind model evaluation and unveil the real-world impact of digital innovation. Parker WS. Model Evaluation: An Adequacy-for-Purpose View. Philos Sci. 2020;87(3):457-477. Bokulich A, Parker W. Data models, representation and adequacy-for-purpose. Eur J Philos Sci. 2021;11(31).

    19 min
Ver todo (43)

Calificaciones y reseรฑas

Acerca de

๐—œ๐—ป ๐—ฆ๐—ถ๐—น๐—ถ๐—ฐ๐—ผ ๐— ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ถ๐—ป๐—ฒ ๐—ฅ๐—ฒ๐˜ƒ๐—ผ๐—น๐˜‚๐˜๐—ถ๐—ผ๐—ป: ๐—จ๐—ž ๐—–๐—˜๐—ถ๐—ฅ๐—ฆ๐—œโ€™๐˜€ ๐—ข๐—ณ๐—ณ๐—ถ๐—ฐ๐—ถ๐—ฎ๐—น ๐—ฃ๐—ผ๐—ฑ๐—ฐ๐—ฎ๐˜€๐˜ on ๐—ฉ๐—ถ๐—ฟ๐˜๐˜‚๐—ฎ๐—น ๐—–๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐—ง๐—ฟ๐—ถ๐—ฎ๐—น๐˜€ & ๐—›๐—ฒ๐—ฎ๐—น๐˜๐—ต๐—ฐ๐—ฎ๐—ฟ๐—ฒ ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป Welcome to the official podcast of the ๐—จ๐—ž ๐—–๐—ฒ๐—ป๐˜๐—ฟ๐—ฒ ๐—ผ๐—ณ ๐—˜๐˜…๐—ฐ๐—ฒ๐—น๐—น๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ผ๐—ป ๐—œ๐—ป ๐—ฆ๐—ถ๐—น๐—ถ๐—ฐ๐—ผ ๐—ฅ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐˜๐—ผ๐—ฟ๐˜† ๐—ฆ๐—ฐ๐—ถ๐—ฒ๐—ป๐—ฐ๐—ฒ ๐—ฎ๐—ป๐—ฑ ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป (๐—จ๐—ž ๐—–๐—˜๐—ถ๐—ฅ๐—ฆ๐—œ) and the ๐—œ๐—ป๐—ฆ๐—ถ๐—น๐—ถ๐—ฐ๐—ผ๐—จ๐—ž ๐—ฃ๐—ฟ๐—ผ ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ฅ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€ ๐—ก๐—ฒ๐˜๐˜„๐—ผ๐—ฟ๐—ธ. Discover how ๐—ฐ๐—ผ๐—บ๐—ฝ๐˜‚๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐—บ๐—ผ๐—ฑ๐—ฒ๐—น๐—น๐—ถ๐—ป๐—ด and ๐˜ƒ๐—ถ๐—ฟ๐˜๐˜‚๐—ฎ๐—น ๐—ฐ๐—น๐—ถ๐—ป๐—ถ๐—ฐ๐—ฎ๐—น ๐˜๐—ฟ๐—ถ๐—ฎ๐—น๐˜€ are transforming healthcare: ๐Ÿ”ฌ ๐——๐—ถ๐—ด๐—ถ๐˜๐—ฎ๐—น ๐—›๐—ฒ๐—ฎ๐—น๐˜๐—ต ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป: Explore breakthrough virtual testing methods for medical devices and pharmaceuticals ๐Ÿฅ ๐—›๐—ฒ๐—ฎ๐—น๐˜๐—ต๐—ฐ๐—ฎ๐—ฟ๐—ฒ ๐—ง๐—ฒ๐—ฐ๐—ต๐—ป๐—ผ๐—น๐—ผ๐—ด๐˜†: Learn about ๐—ถ๐—ป ๐˜€๐—ถ๐—น๐—ถ๐—ฐ๐—ผ evidence revolutionising patient care ๐Ÿ’ป ๐—–๐—ผ๐—บ๐—ฝ๐˜‚๐˜๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐— ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ถ๐—ป๐—ฒ: Understand how ๐—ฑ๐—ถ๐—ด๐—ถ๐˜๐—ฎ๐—น ๐˜๐˜„๐—ถ๐—ป๐˜€ and computer simulations accelerate drug development ๐Ÿค ๐—ฅ๐—ฒ๐—ด๐˜‚๐—น๐—ฎ๐˜๐—ผ๐—ฟ๐˜† ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป: Join experts discussing streamlined approval processes for medical innovations ๐Ÿ“ˆ ๐—›๐—ฒ๐—ฎ๐—น๐˜๐—ต๐—ฐ๐—ฎ๐—ฟ๐—ฒ ๐—˜๐—ฐ๐—ผ๐—ป๐—ผ๐—บ๐—ถ๐—ฐ๐˜€: Explore cost-effective solutions driving medical advancement ๐Ÿ”” ๐——๐—ผ๐—ปโ€™๐˜ ๐—บ๐—ถ๐˜€๐˜€ ๐—ผ๐˜‚๐˜! Follow us across platforms to stay updated with the latest in ๐—ถ๐—ป ๐˜€๐—ถ๐—น๐—ถ๐—ฐ๐—ผ innovations, regulatory developments, and groundbreaking research. Join the conversation and become part of the ๐—จ๐—ž ๐—–๐—˜๐—ถ๐—ฅ๐—ฆ๐—œ community shaping the future of healthcare! ๐Ÿš€

Informaciรณn

  • Creador
    UK CEiRSI | InSilicoUK
  • Aรฑos de actividad
    2024 - 2025
  • Episodios
    43
  • Clasificaciรณn
    Apto
  • Copyright
    ยฉ Copyright @ 2024-2025 All rights reserved.
  • Mostrar sitio web
    In Silico Trials, Real Impacts!